Australia markets closed

Madrigal Pharmaceuticals, Inc. (MDGL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
276.01-0.71 (-0.26%)
At close: 04:00PM EDT
276.40 +0.39 (+0.14%)
After hours: 06:18PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts14141616
Avg. Estimate-7.56-7.07-27.99-17.82
Low estimate-9.37-8.19-34.17-26
High estimate-6.52-5.82-19.13-6.54
Year ago EPS-4.69-5.34-19.99-27.99
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts13141214
Avg. Estimate3.79M22.65M82.28M364.17M
Low estimate900k15M61.11M201.78M
High estimate5.6M35M98.5M509.22M
Year ago salesN/AN/AN/A82.28M
Sales growth (year/est)N/AN/AN/A342.60%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-4.58-4.92-5.28-6.28
Actual EPS-4.69-5.34-5.68-7.38
Difference-0.11-0.42-0.4-1.1
Surprise %-2.40%-8.50%-7.60%-17.50%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-7.56-7.07-27.99-17.82
7 days ago-7.56-7.07-27.99-17.82
30 days ago-7.66-7.2-28.18-18.14
60 days ago-6.62-6.15-23.48-14.46
90 days ago-6.62-6.15-23.48-14.46
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A11
Up last 30 days1112
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMDGLIndustrySector(s)S&P 500
Current qtr.-61.20%N/AN/AN/A
Next qtr.-32.40%N/AN/AN/A
Current year-40.00%N/AN/AN/A
Next year36.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A